N-[(2S)-6-amino-1-[[(2S,3R)-1-[[(2S)-6-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(4-aminobutyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]hexan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]-6-methyloctanamide

C66H118N16O13 — CID 46883658

IUPACN-[(2S)-6-amino-1-[[(2S,3R)-1-[[(2S)-6-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(4-aminobutyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]hexan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]-6-methyloctanamide
SMILESCCC(C)CCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCCCN)NC1=O)[C@@H](C)O
InChIInChI=1S/C66H118N16O13/c1-7-42(4)23-11-12-31-54(85)73-46(26-13-18-33-67)61(90)82-56(44(6)84)66(95)78-49(29-16-21-36-70)58(87)77-51-32-38-72-65(94)55(43(5)83)81-62(91)50(30-17-22-37-71)75-57(86)47(27-14-19-34-68)76-63(92)52(39-41(2)3)79-64(93)53(40-45-24-9-8-10-25-45)80-59(88)48(74-60(51)89)28-15-20-35-69/h8-10,24-25,41-44,46-53,55-56,83-84H,7,11-23,26-40,67-71H2,1-6H3,(H,72,94)(H,73,85)(H,74,89)(H,75,86)(H,76,92)(H,77,87)(H,78,95)(H,79,93)(H,80,88)(H,81,91)(H,82,90)/t42?,43-,44-,46+,47+,48+,49+,50+,51+,52+,53-,55+,56+/m1/s1
InChIKeyGENGXRCPLDUPFQ-OMWLLSHESA-N
MW1343.77 g/mol
LogP-1.34
Rot. Bonds39

About N-[(2S)-6-amino-1-[[(2S,3R)-1-[[(2S)-6-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(4-aminobutyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]hexan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]-6-methyloctanamide

N-[(2S)-6-amino-1-[[(2S,3R)-1-[[(2S)-6-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(4-aminobutyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]hexan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]-6-methyloctanamide (PubChem CID 46883658) has the molecular formula C66H118N16O13 and a molecular weight of 1343.77 g/mol. Its IUPAC name is N-[(2S)-6-amino-1-[[(2S,3R)-1-[[(2S)-6-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(4-aminobutyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]hexan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]-6-methyloctanamide.

Molecular Properties

Compound NameN-[(2S)-6-amino-1-[[(2S,3R)-1-[[(2S)-6-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(4-aminobutyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]hexan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]-6-methyloctanamide
PubChem CID46883658
Molecular FormulaC66H118N16O13
Molecular Weight1343.77 g/mol
Exact Mass1342.91
IUPAC NameN-[(2S)-6-amino-1-[[(2S,3R)-1-[[(2S)-6-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(4-aminobutyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]hexan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]-6-methyloctanamide
SMILESCCC(C)CCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCCCN)NC1=O)[C@@H](C)O
InChIInChI=1S/C66H118N16O13/c1-7-42(4)23-11-12-31-54(85)73-46(26-13-18-33-67)61(90)82-56(44(6)84)66(95)78-49(29-16-21-36-70)58(87)77-51-32-38-72-65(94)55(43(5)83)81-62(91)50(30-17-22-37-71)75-57(86)47(27-14-19-34-68)76-63(92)52(39-41(2)3)79-64(93)53(40-45-24-9-8-10-25-45)80-59(88)48(74-60(51)89)28-15-20-35-69/h8-10,24-25,41-44,46-53,55-56,83-84H,7,11-23,26-40,67-71H2,1-6H3,(H,72,94)(H,73,85)(H,74,89)(H,75,86)(H,76,92)(H,77,87)(H,78,95)(H,79,93)(H,80,88)(H,81,91)(H,82,90)/t42?,43-,44-,46+,47+,48+,49+,50+,51+,52+,53-,55+,56+/m1/s1
InChIKeyGENGXRCPLDUPFQ-OMWLLSHESA-N
XLogP-1.34
TPSA490.66 Ų
H-Bond Donors18
H-Bond Acceptors18
Rotatable Bonds39
Heavy Atoms95
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001343.77
LogP ≤ 5-1.34
H-Bond Donors ≤ 518
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[(2S)-6-amino-1-[[(2S,3R)-1-[[(2S)-6-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(4-aminobutyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]hexan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]-6-methyloctanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(2S)-6-amino-1-[[(2S,3R)-1-[[(2S)-6-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(4-aminobutyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]hexan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]-6-methyloctanamide?
The IUPAC name of N-[(2S)-6-amino-1-[[(2S,3R)-1-[[(2S)-6-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(4-aminobutyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]hexan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]-6-methyloctanamide (CID 46883658) is N-[(2S)-6-amino-1-[[(2S,3R)-1-[[(2S)-6-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(4-aminobutyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]hexan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]-6-methyloctanamide.
What is the SMILES notation for N-[(2S)-6-amino-1-[[(2S,3R)-1-[[(2S)-6-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(4-aminobutyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]hexan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]-6-methyloctanamide?
The canonical SMILES for N-[(2S)-6-amino-1-[[(2S,3R)-1-[[(2S)-6-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(4-aminobutyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]hexan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]-6-methyloctanamide is CCC(C)CCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCCCN)NC1=O)[C@@H](C)O.
What is the InChIKey of N-[(2S)-6-amino-1-[[(2S,3R)-1-[[(2S)-6-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(4-aminobutyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]hexan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]-6-methyloctanamide?
The InChIKey is GENGXRCPLDUPFQ-OMWLLSHESA-N. The full InChI is InChI=1S/C66H118N16O13/c1-7-42(4)23-11-12-31-54(85)73-46(26-13-18-33-67)61(90)82-56(44(6)84)66(95)78-49(29-16-21-36-70)58(87)77-51-32-38-72-65(94)55(43(5)83)81-62(91)50(30-17-22-37-71)75-57(86)47(27-14-19-34-68)76-63(92)52(39-41(2)3)79-64(93)53(40-45-24-9-8-10-25-45)80-59(88)48(74-60(51)89)28-15-20-35-69/h8-10,24-25,41-44,46-53,55-56,83-84H,7,11-23,26-40,67-71H2,1-6H3,(H,72,94)(H,73,85)(H,74,89)(H,75,86)(H,76,92)(H,77,87)(H,78,95)(H,79,93)(H,80,88)(H,81,91)(H,82,90)/t42?,43-,44-,46+,47+,48+,49+,50+,51+,52+,53-,55+,56+/m1/s1.
What are the key properties of N-[(2S)-6-amino-1-[[(2S,3R)-1-[[(2S)-6-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(4-aminobutyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]hexan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]-6-methyloctanamide?
N-[(2S)-6-amino-1-[[(2S,3R)-1-[[(2S)-6-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(4-aminobutyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]hexan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]-6-methyloctanamide has a molecular weight of 1343.77 g/mol, XLogP of -1.34, 39 rotatable bonds, 18 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(2S)-6-amino-1-[[(2S,3R)-1-[[(2S)-6-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(4-aminobutyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]hexan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]-6-methyloctanamide is sourced from PubChem (CID 46883658), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).